Related Experiment Video
Updated: Jan 8, 2026

07:18
Author Spotlight: New Insights into PBMC Mitochondrial Responses Using Fluorespirometry
Published on: May 24, 2024
1.6K
Lipoteichoic Acid Stimulation of Macrophages Causes Mitochondrial Dysfunction
Siyao Liu1, Xin Liu2, Guixin Li3
1The First Affiliated Hospital of Harbin Medical University and Department of Endodontics, School of Stomatology, Harbin Medical University, Harbin, P. R. China.
International Dental Journal
|December 20, 2025
Summary
Mitochondrial dysfunction drives inflammation in refractory apical periodontitis. Targeting mitochondrial dynamics with Mdivi-1 restores function and reduces inflammation, offering a novel therapeutic approach.
Area of Science:
- Oral biology
- Immunology
- Mitochondrial biology
Background:
- Refractory apical periodontitis involves complex inflammatory processes.
- Enterococcus faecalis lipoteichoic acid (LTA) is implicated in disease pathogenesis.
- The role of mitochondrial dysfunction in this context requires further investigation.
Purpose of the Study:
- To investigate mitochondrial dysfunction in LTA-induced apical periodontitis.
- To evaluate the therapeutic potential of modulating mitochondrial dynamics using Mdivi-1.
Main Methods:
- Established an LTA-induced macrophage model to mimic apical periodontitis.
- Analyzed inflammatory factors, mitochondrial morphology, dynamics proteins, autophagy, and reactive oxygen species (ROS).
- Assessed the effects of the mitochondrial division inhibitor Mdivi-1.
Main Results:
- E. faecalis infection induced apical periodontitis with bone loss and inflammation.
- LTA stimulation increased inflammatory mediators and caused mitochondrial dysfunction (disruption, impaired autophagy, elevated ROS).
- Mdivi-1 treatment improved mitochondrial function and reduced inflammation.
Conclusions:
- Mitochondrial dysfunction is central to LTA-driven inflammation in apical periodontitis.
- Targeting mitochondrial dynamics with Mdivi-1 mitigates inflammation and restores mitochondrial function.
- This suggests Mdivi-1 as a potential therapeutic strategy for refractory apical periodontitis.

